
Blog
SV95C: What Does It Take to Qualify a Digital Endpoint?
In July 2023, the European Medicines Agency (EMA) granted qualification to SV95C (Stride Velocity 95th Centile) as a primary endpoint for clinical trials in ambulatory
Home > News and White papers > News > L’étude Syde-CAR
La vidéo Formation Syde ® pour l’Etude SYDE-CAR
QUESTIONNAIRE DE FORMATION AU SYDE®
Question 3 : Quel est le positionnement correct ?

In July 2023, the European Medicines Agency (EMA) granted qualification to SV95C (Stride Velocity 95th Centile) as a primary endpoint for clinical trials in ambulatory

How do you assess a patient too young to follow instructions? That’s the challenge our Program Director, Damien Eggenspieler, tackled on the ground at ICNMD

Can a single wearable platform derive meaningful clinical conclusions across 10+ neurological diseases? The evidence says yes.We’re presenting three new posters at EAN 2025, each